KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) EBT Margin (2016 - 2025)

Historic EBT Margin for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to 11.65%.

  • Quest Diagnostics' EBT Margin fell 2500.0% to 11.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.86%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 11.9% for FY2024, which is 3100.0% down from last year.
  • Quest Diagnostics' EBT Margin amounted to 11.65% in Q3 2025, which was down 2500.0% from 13.91% recorded in Q2 2025.
  • Quest Diagnostics' 5-year EBT Margin high stood at 32.04% for Q2 2021, and its period low was 4.67% during Q4 2022.
  • In the last 5 years, Quest Diagnostics' EBT Margin had a median value of 13.1% in 2024 and averaged 14.66%.
  • Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 180800bps in 2021, then plummeted by -188700bps in 2022.
  • Over the past 5 years, Quest Diagnostics' EBT Margin (Quarter) stood at 18.29% in 2021, then tumbled by -74bps to 4.67% in 2022, then surged by 122bps to 10.36% in 2023, then grew by 10bps to 11.41% in 2024, then increased by 2bps to 11.65% in 2025.
  • Its EBT Margin was 11.65% in Q3 2025, compared to 13.91% in Q2 2025 and 10.41% in Q1 2025.